United States · 
Who invested in Rivus Pharmaceuticals?
Rivus Pharmaceuticals's investors include RA Capital Management, Longitude Capital and Bain Capital Life Sciences.
United States · Venture startup
Who invested in Rivus Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$57Mraised across 1 round since 2025, from 1 source
- Latest round
- Venture, $57MJan 2025
- Investors
- 3
The rounds
- Jan 2025Venture$57M
Source recordedSEC filing: $57M sold, first sale Jan 2025
Founders and team
From Rivus Pharmaceuticals's own website: 6 on the team.
- Jorge BartolomeChief Executive Officer
- Allen CunninghamChief Operating Officer
- Derek DiRoccoDirector
- Erin LavelleDirector
- Ian F. SmithCo-Chair of the Board
- Rick E. WinninghamDirector
Everyone who backed them
Bain Capital Life SciencesPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Rivus Pharmaceuticals
How much has Rivus Pharmaceuticals raised?
Rivus Pharmaceuticals has raised $57M across 1 round since 2025.
When did Rivus Pharmaceuticals last raise?
Rivus Pharmaceuticals's most recent round was a Venture of $57M in Jan 2025.
What was Rivus Pharmaceuticals's biggest round?
Its most recent round, $57M in Jan 2025, is also its largest on record.
Who backed Rivus Pharmaceuticals first?
Rivus Pharmaceuticals's first round on record, in Jan 2025, was backed by RA Capital Management, Longitude Capital and Bain Capital Life Sciences.
What stage is Rivus Pharmaceuticals at?
Rivus Pharmaceuticals's latest named round is a Venture, in Jan 2025.
Where is Rivus Pharmaceuticals based?
Rivus Pharmaceuticals is based in the United States.
Companies like Rivus Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.